Merck Q1 Earnings Beat
Description
Merck beat estimates on strong cancer drug demand despite a large acquisition charge.
More from User
00:53
India IPO Demand Surges
Benzinga
00:55
Airbnb CEO X Account Hacked
Benzinga
00:50
ConocoPhillips Buys BP Stake
Benzinga
00:56
Coca-Cola Stock Rises
Benzinga
00:51
FDA Approves Merck Pill
Benzinga
00:58
Fossil Trims Store Network
Benzinga
Related Videos
01:12
Lululemon Q1 Earnings: Revenue Beat, EPS In Line, Shares Tumble On Weaker Earnings Forecast
Benzinga
03:18
FedEx Earnings Highlights: FedEx Delivers Mixed Q1 Results: Lowers Revenue Outlook, Increases Earnings Guidance, Shares Spring Higher
Benzinga
00:55
Asana Stock Climbs On Mixed Q1 Earnings: Earnings Beat, Revenues Miss
Benzinga
00:53
McDonald's Earnings: Revenues Hit, While EPS Misses In Q1 Earnings Report
Benzinga
00:46
Merck Q1 revenue drops by 9% due to steep decline in Covid antiviral sales
Benzinga
00:42
Costco Tops Wall Street Estimates With Strong Q1 Earnings, Revenue Growth
Benzinga